Cellectis is a French biopharmaceutical company. It develops genome-edited chimeric antigen receptor T-cell technologies for cancer immunotherapy.
Altos Labs
7 followers
Sanofi
500 followers
REVOLUTION Medicines
19 followers
Telix Pharma
8 followers
Summit Therapeutics
8 followers
Rigel Pharmaceuticals
5 followers
Abeona Therapeutics
3 followers
Foghorn Therapeutics
2 followers
BAMF Health
2 followers
Matica Biotechnology
2 followers
Rhythm Pharmaceuticals
5 followers
Rapid Micro Biosystems
1 follower